Health Canada officials to hold a technical briefing regarding a decision for the neonicotinoid imidacloprid

May 18, 2021, OTTAWA, ON - Officials from Health Canada will hold a technical briefing to discuss the final re-evaluation decision for the neonicotinoid imidacloprid.

Officials will be available to answer questions from the media following their remarks.

Date

May 19, 2021

Time

2:00 PM (EDT)

Location

The technical briefing will be held by teleconference only.

Toll-free (Canada/US) dial-in number:
1-866-206-0153
Local dial-in number:
613-954-9003

Passcode: 2112476#

NOTE: To obtain the briefing material under embargo, please RSVP by email at
hc.media.sc@canada.ca.